Sustiva Levels With Use of a Gel Capsule

Completed · Phase 4

Conditions studied: HIV, HIV Infections

In brief

We are studying if putting a gel capsule over a standard HIV drug changes the ability of the body to absorb the drug. This is important because we want to be able to study new HIV drugs against the most common drugs used today and the most common is Sustiva, which is also called efavirenz. We will give you Sustiva every day for 5 days and draw blood to see how much is absorbed. Then we will give you Sustiva that has a gel capsule over it for 5 days and we will draw blood to see how much is absorbed.

Key facts

Study ID

NCT01087814

Run by

University of Minnesota

People needed

16

Starts

2010-02-01

Expected to finish

2011-09-01

Last updated by the study team

2017-03-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• HIV-negative, proven by ELISA
• Age: ≥ 18 years old

You may not qualify if…

• Psychiatric or psychological illness that would make adherence to protocol procedures unlikely.

Where it is running

• University of Minnesota — Minneapolis, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.